Cost‐effectiveness of a proposed feasibility study on the detection of early lung carcinoma in Germany

A randomized, controlled study combining new technologies with more conventional methods for the detection of early lung carcinoma is planned for 6000 high risk patients. A cost‐benefit analysis has shown a projected doubling of the 5‐year survival rate with an approximate 20% increase in total (scr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer 2000-12, Vol.89 (S11), p.2494-2496
1. Verfasser:	Nakhosteen, John A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biological and medical sciences Bronchoscopy - economics Bronchoscopy - methods Carcinoma - diagnosis Carcinoma - economics Carcinoma - epidemiology Carcinoma - prevention & control Cost-Benefit Analysis Feasibility Studies Female Fluorescence Germany - epidemiology Humans Incidence Lung Neoplasms - diagnosis Lung Neoplasms - economics Lung Neoplasms - epidemiology Lung Neoplasms - prevention & control Male Mass Chest X-Ray Mass Screening - economics Mass Screening - methods Medical sciences Middle Aged Neoplasm Staging Pneumology Prevalence Randomized Controlled Trials as Topic - economics Risk Factors Sputum - cytology Tumors of the respiratory system and mediastinum
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A randomized, controlled study combining new technologies with more conventional methods for the detection of early lung carcinoma is planned for 6000 high risk patients. A cost‐benefit analysis has shown a projected doubling of the 5‐year survival rate with an approximate 20% increase in total (screening and treatment) costs in the screened group compared with the control group.
ISSN:	0008-543X 1097-0142
DOI:	10.1002/1097-0142(20001201)89:11+<2494::AID-CNCR30>3.0.CO;2-H